A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

By L. Backus, D. Boothroyd, B. Phillips, P. Belperio, J. Halloran, L. Mole. Clinical Gastroenterology and Hepatology, 2011

625 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. (2012, neutral): “5%) are living with hepatitis C virus (HCV) infection (1), and an estimated 17,000 persons were newly infected in 2010, the most recent year that data are available (2).”
Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (2019, background): “(31,32) Given the current epidemiology of HCV disease in the United States, the cost-effectiveness of universal HCV screening, the high efficacy of DAA therapy, and the myriad liver-related and other health benefits of virologic cure,(33-38) the HCV guidance panel recommends universal, one-time, opt”
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma (2013, background): “Sustained virologic response has been associated with a 54% reduction in all-cause mortality (14), and persons who achieve it typically show histologic improvement (15) and are at lower”
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. (2012, neutral): “History of severe alcohol use 119/494 (24) 31/120 (26) 88/374 (24) .”